Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Other assay [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1-16991 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- OPA1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- This antibody shares 100% sequence homology with primate, 94% with zebrafish. Suggested positive control: human brain protein.
- Reactivity
- Human, Mouse, Rat, Chicken/Avian, Porcine, Zebrafish
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Temperature-Related Effects of Myocardial Protection Strategies in Swine Hearts after Prolonged Warm Ischemia.
Tau Deletion Prevents Cognitive Impairment and Mitochondrial Dysfunction Age Associated by a Mechanism Dependent on Cyclophilin-D.
Intracardiac administration of ephrinA1-Fc preserves mitochondrial bioenergetics during acute ischemia/reperfusion injury.
Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus.
Quantitative proteomic and functional analysis of liver mitochondria from high fat diet (HFD) diabetic mice.
Tolomeo AM, Fabozzo A, Malvicini R, De Lazzari G, Bisaccia P, Gaburro G, Arcidiacono D, Notarangelo D, Caicci F, Zanella F, Marchesan M, Yannarelli G, Santovito G, Muraca M, Gerosa G
Antioxidants (Basel, Switzerland) 2022 Feb 28;11(3)
Antioxidants (Basel, Switzerland) 2022 Feb 28;11(3)
Tau Deletion Prevents Cognitive Impairment and Mitochondrial Dysfunction Age Associated by a Mechanism Dependent on Cyclophilin-D.
Jara C, Cerpa W, Tapia-Rojas C, Quintanilla RA
Frontiers in neuroscience 2020;14:586710
Frontiers in neuroscience 2020;14:586710
Intracardiac administration of ephrinA1-Fc preserves mitochondrial bioenergetics during acute ischemia/reperfusion injury.
Torres MJ, McLaughlin KL, Renegar RH, Valsaraj S, Whitehurst KS, Sharaf OM, Sharma UM, Horton JL, Sarathy B, Parks JC, Brault JJ, Fisher-Wellman KH, Neufer PD, Virag JAI
Life sciences 2019 Dec 15;239:117053
Life sciences 2019 Dec 15;239:117053
Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus.
Jara C, Aránguiz A, Cerpa W, Tapia-Rojas C, Quintanilla RA
Redox biology 2018 Sep;18:279-294
Redox biology 2018 Sep;18:279-294
Quantitative proteomic and functional analysis of liver mitochondria from high fat diet (HFD) diabetic mice.
Guo Y, Darshi M, Ma Y, Perkins GA, Shen Z, Haushalter KJ, Saito R, Chen A, Lee YS, Patel HH, Briggs SP, Ellisman MH, Olefsky JM, Taylor SS
Molecular & cellular proteomics : MCP 2013 Dec;12(12):3744-58
Molecular & cellular proteomics : MCP 2013 Dec;12(12):3744-58
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 2 Effects of tau deletion on the levels of proteins involved in mitochondrial dynamics and structure. ( A ) Representative western blot of hippocampal lysates and densitometric analysis of proteins involved in mitochondrial fusion, such as Mnf1, Mnf2, and Opa1. ( B ) Representative western blot of hippocampal lysates and densitometric analysis of proteins involved in mitochondrial fission, including phospho-Drp1, total Drp1, and Fis1. ( C ) Western blot of hippocampal lysates and densitometric analysis of proteins that form the mitochondrial permeability transition pore (mPTP), such as Cyp-D, VDAC, and ANT. ( D-F ) Relative mRNA expression of Cyp-D, VDAC, and ANT in the hippocampus of WT and tau -/- animals. *p < 0.05, **p < 0.01; data are presented as the mean +- SE. n = 4 different animals for WT group and n = 5 different animals for tau -/- group. Fig. 2
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Detection of OPA1 in heart tissue. Quantitative results ( A ) and representative Western blots ( B ) of OPA1 of different heart regions treated with different cardioplegia solutions. TOM40 was used as loading control. Values are shown as median +- range, n = 3. BL: baseline; CC: cardioplegia; CC-ADN: cardioplegia supplemented with adenosine; NtC + CC: 250 mL warm cardioplegia + 750 mL cold cardioplegia; NtC-ADN + CC: 250 mL warm cardioplegia supplemented with adenosine + 750 mL cold cardioplegia.